Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
- PMID:16731270
- DOI: 10.1016/S0140-6736(06)68770-9
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
Abstract
Background: Our aim was to calculate the global burden of disease and risk factors for 2001, to examine regional trends from 1990 to 2001, and to provide a starting point for the analysis of the Disease Control Priorities Project (DCPP).
Methods: We calculated mortality, incidence, prevalence, and disability adjusted life years (DALYs) for 136 diseases and injuries, for seven income/geographic country groups. To assess trends, we re-estimated all-cause mortality for 1990 with the same methods as for 2001. We estimated mortality and disease burden attributable to 19 risk factors.
Findings: About 56 million people died in 2001. Of these, 10.6 million were children, 99% of whom lived in low-and-middle-income countries. More than half of child deaths in 2001 were attributable to acute respiratory infections, measles, diarrhoea, malaria, and HIV/AIDS. The ten leading diseases for global disease burden were perinatal conditions, lower respiratory infections, ischaemic heart disease, cerebrovascular disease, HIV/AIDS, diarrhoeal diseases, unipolar major depression, malaria, chronic obstructive pulmonary disease, and tuberculosis. There was a 20% reduction in global disease burden per head due to communicable, maternal, perinatal, and nutritional conditions between 1990 and 2001. Almost half the disease burden in low-and-middle-income countries is now from non-communicable diseases (disease burden per head in Sub-Saharan Africa and the low-and-middle-income countries of Europe and Central Asia increased between 1990 and 2001). Undernutrition remains the leading risk factor for health loss. An estimated 45% of global mortality and 36% of global disease burden are attributable to the joint hazardous effects of the 19 risk factors studied. Uncertainty in all-cause mortality estimates ranged from around 1% in high-income countries to 15-20% in Sub-Saharan Africa. Uncertainty was larger for mortality from specific diseases, and for incidence and prevalence of non-fatal outcomes.
Interpretation: Despite uncertainties about mortality and burden of disease estimates, our findings suggest that substantial gains in health have been achieved in most populations, countered by the HIV/AIDS epidemic in Sub-Saharan Africa and setbacks in adult mortality in countries of the former Soviet Union. Our results on major disease, injury, and risk factor causes of loss of health, together with information on the cost-effectiveness of interventions, can assist in accelerating progress towards better health and reducing the persistent differentials in health between poor and rich countries.
Comment in
- Global burden of disease and visual impairment.Chiang PP, Keeffe JE, Le Mesurier RT, Taylor HR.Chiang PP, et al.Lancet. 2006 Jul 29;368(9533):365. doi: 10.1016/S0140-6736(06)69105-8.Lancet. 2006.PMID:16876661No abstract available.
Similar articles
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March …See abstract for full author list ➔Lozano R, et al.Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.Lancet. 2012.PMID:23245604Free PMC article.
- Mortality by cause for eight regions of the world: Global Burden of Disease Study.Murray CJ, Lopez AD.Murray CJ, et al.Lancet. 1997 May 3;349(9061):1269-76. doi: 10.1016/S0140-6736(96)07493-4.Lancet. 1997.PMID:9142060
- Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.Murray CJ, Lopez AD.Murray CJ, et al.Lancet. 1997 May 17;349(9063):1436-42. doi: 10.1016/S0140-6736(96)07495-8.Lancet. 1997.PMID:9164317
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Global Burden of Disease Study 2013 Collaborators.Global Burden of Disease Study 2013 Collaborators.Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.Lancet. 2015.PMID:26063472Free PMC article.Review.
- Measuring the global burden of disease and epidemiological transitions: 2002-2030.Lopez AD, Mathers CD.Lopez AD, et al.Ann Trop Med Parasitol. 2006 Jul-Sep;100(5-6):481-99. doi: 10.1179/136485906X97417.Ann Trop Med Parasitol. 2006.PMID:16899150Review.
Cited by
- Ethics in Global Plastic Surgery Missions.Chikoti R, Leon SJ, Thornburg D, Kandi L, Morris B, Rebecca A, Casey W, Howard MA, Teven CM.Chikoti R, et al.Plast Reconstr Surg Glob Open. 2024 Oct 25;12(10):e6245. doi: 10.1097/GOX.0000000000006245. eCollection 2024 Oct.Plast Reconstr Surg Glob Open. 2024.PMID:39465040Free PMC article.
- Therapeutics targeting Nogo-A hold promise for stroke restoration.Kumar P, Moon LD.Kumar P, et al.CNS Neurol Disord Drug Targets. 2013 Mar;12(2):200-8. doi: 10.2174/1871527311312020006.CNS Neurol Disord Drug Targets. 2013.PMID:23394537Free PMC article.Review.
- Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats.Panchal SK, Brown L.Panchal SK, et al.Eur J Nutr. 2013 Feb;52(1):397-408. doi: 10.1007/s00394-011-0277-1. Epub 2011 Nov 22.Eur J Nutr. 2013.PMID:22105311
- Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study.Krämer HU, Raum E, Rüter G, Schöttker B, Rothenbacher D, Rosemann T, Szecsenyi J, Brenner H.Krämer HU, et al.Cardiovasc Diabetol. 2012 Jul 27;11:88. doi: 10.1186/1475-2840-11-88.Cardiovasc Diabetol. 2012.PMID:22838970Free PMC article.
- Prehospital Emergency Care: A Cross-Sectional Survey of First-Aid Preparedness Among Layperson First Responders in Northern Uganda.Opiro K, Amone D, Sikoti M, Wokorach A, Okot J, Bongomin F.Opiro K, et al.Open Access Emerg Med. 2024 Jul 19;16:191-202. doi: 10.2147/OAEM.S464793. eCollection 2024.Open Access Emerg Med. 2024.PMID:39050491Free PMC article.
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical